VISEN PHARMACEUTICALS - B
(HKEX: 2561)
VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Suzhou, China.
35.660 -
+0.340
(+0.96%)
Range
34.720 - 36.820
(6.05%)
Open
36.820
Previous Close
35.320
Bid Price
35.200
Bid Volume
('000)
0.6
Ask Price
35.660
Ask Volume
('000)
4.7
Volume
('000)
23.3
Value
831,646
Remark
-
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
